Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors through Rational Design
Open Access
- 12 April 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 2 (6) , 288-293
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Small Molecules Showing Significant Protection of Mice against Botulinum Neurotoxin Serotype APLOS ONE, 2010
- Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctionsNeuropharmacology, 2010
- Chirality Holds the Key for Potent Inhibition of the Botulinum Neurotoxin Serotype A ProteaseOrganic Letters, 2010
- Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular DesignPLOS ONE, 2009
- Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxinsToxicon, 2009
- Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrationsChemical Communications, 2008
- Synthesis and structure–activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonistsProceedings of the National Academy of Sciences, 2007
- An Outbreak of Botulism in Thailand: Clinical Manifestations and Management of Severe Respiratory FailureClinical Infectious Diseases, 2006
- Identification of a Potent Botulinum Neurotoxin A Protease Inhibitor Using in Situ Lead Identification ChemistryOrganic Letters, 2006